Sato, K. et al. Humanization of a mouse anti-human interleukin-6 receptor antibody comparing two methods for selecting human framework regions. Molecular Immunology, 31(5): 371-381, 1994.* |
Suzuki, H. et al. Anti-human interleukin-6 receptor antibody inhibits myeloma growth in vivo. Eur. J. Immunol. 22: 1989-1993, 1992.* |
Suzuki, H. et al. Anti-murin IL-6 receptor antibody inhibits IL-6 effects in vivo. Immunology Letters, 30: 17-21, 1991.* |
Evans, T.L. et al. In vitro degadation of L-phenylalanine mustard (L-PAM). Cancer Chemotherapy and Pharmacology, 8(2): 175-178, 1982.* |
Sarosy, G. et al. The systemic administration of intravenous melphalan. Journal of Clinical Oncology 6(11): 1768-1782, Nov. 1988.* |
Budavari, S. et al. (Eds.) The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals 12 Ed.; Whitehouse Station, NJ pp. 344, 463, 841, 842, 984, and 993 (1996). |
Manning et al, “Assessment of the therapeutic potential of cytokines, cytotoxic drugs and effector cell populations for the treatment of multiple myeloma using the 5T33 murine myeloma model”, Immunology and Cell Biology (1995) vol. 73, No. 4, pp. 326-332. |
Anthes et al, “Interferon-{acute over (α)} down-regulates the interleukin-6 receptor in a human multiple myeloma cell line, U266”, Biochem J., 1995, vol. 309, No. 1, pp. 175-180. |